Neu Base Therapeutics Inc (NBSE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
| 09-2017 | 09-2016 | 09-2015 | 09-2014 | 09-2013 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -23,811 | -25,766 | -15,198 | -9,131 | -5,653 |
| Depreciation Amortization | 1,166 | 1,189 | 1,518 | 466 | 91 |
| Other Working Capital | 1,312 | 4,633 | -1,299 | 42 | 402 |
| Other Operating Activity | 2,043 | 3,958 | 4,286 | 3,262 | 2,470 |
| Operating Cash Flow | $-19,291 | $-15,986 | $-10,693 | $-5,360 | $-2,690 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 89 | -15 | -185 | -3,501 | N/A |
| Purchase Of Investment | N/A | N/A | -100 | -14 | N/A |
| Investing Cash Flow | $89 | $-15 | $-285 | $-3,515 | $0 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 19,700 | 26 | 26,663 | 17,137 | 5,252 |
| Other Financing Activity | -243 | -176 | -208 | -164 | -72 |
| Financing Cash Flow | $19,457 | $-150 | $26,455 | $16,973 | $5,180 |
| Beginning Cash Position | 12,547 | 28,697 | 13,221 | 5,123 | 2,632 |
| End Cash Position | 12,801 | 12,547 | 28,697 | 13,221 | 5,123 |
| Net Cash Flow | $254 | $-16,150 | $15,477 | $8,098 | $2,491 |
| Free Cash Flow | |||||
| Operating Cash Flow | -19,291 | -15,986 | -10,693 | -5,360 | -2,690 |
| Capital Expenditure | -5 | -15 | -185 | -3,501 | N/A |
| Free Cash Flow | -19,296 | -16,000 | -10,878 | -8,861 | -2,690 |